244 results
Page 7 of 13
8-K
7molk3 cyxmu
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
EX-99.1
j9ulic4
8 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
2uzbl807v8so
2 Feb 12
Other Events
12:00am
424B5
o4v6m4c aaa5og9s2pp
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
onv7q271zprlqw8i9
28 Sep 11
Other Events
12:00am
8-K
3q1k1
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
wn7hp9d253iqr9
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
gsoln4r
1 Jun 11
Other Events
12:00am
424B5
yelx0d
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
fru497r1
15 Feb 11
Prospectus supplement for primary offering
12:00am
CORRESP
te9vmzn
10 Nov 10
Correspondence with SEC
12:00am
CORRESP
cpk63d
8 Nov 10
Correspondence with SEC
12:00am